[Remote] (Senior) Medical Science Liaison - Sunbelt at Tempus

Alabama, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Fundamental understanding of the field of molecular oncology and related patient management algorithms
Existing KOL relationships in the field of oncology
Working knowledge of genomic laboratory-developed testing (LDT)
Familiarity with CLIA-88’, CAP, Sunshine Act (2013)
Public speaking skills and ability to effectively communicate relevant scientific topics and concepts
Exceptional interpersonal communication skills, strong inter-, and intradepartmental management skills, ability to educate and train
Self-starter with an ownership mindset able to work and deliver on tight timelines
Ability to travel (up to 50%)
Advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN)
Basic understanding of oncology required
Basic understanding of molecular testing strongly preferred

Responsibilities

Function as sales and commercial team support and a regional expert with respect to Tempus oncology assays, promoting exchange of clinical/scientific/technical information with regional KOLs and other physicians in the field of oncology
Facilitate education of a broader healthcare provider community within the region (KOLs, community physicians, medical directors, and other HCPs) regarding Tempus oncology products via in-person or virtual presentations
Provide scientific education for internal stakeholders in collaboration with Learning & Development team
Attend conferences and other key meetings and provide comprehensive meeting synopses and summaries of high-impact abstracts/posters/oral presentations
Continuously update internal stakeholders on relevant medical and scientific knowledge as well as proactively sharing market intelligence

Skills

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free